From: Establishing a Cancer Genetics Programme in Asia - the Singapore Experience
patients who underwent genetic testing (n = 127) | |
---|---|
   test category | % |
BRCA1/2 comprehensive sequencing | 42 |
MLH1/MSH2 sequencing | 52 |
APC protein truncation test | 2 |
othersa | 4 |
patients with germline deleterious mutation identified (n = 29) | % |
   BRCA1/2 mutation | 59 |
   MLH1/MSH2 mutation | 31 |
   APC mutation | 3 |
   othersb | 7 |